Juan J. Cruz

Salamanca, CL, ES 
Salamanca, CL, ES 

Overview

Juan Cruz practices practicing medicine in Salamanca, Spain.

His clinical expertise encompasses Febrile Neutropenia and Agranulocytosis.

He is actively involved in clinical research, co-authoring 23 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Salamanca, CL, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Open Label Randomized, Multi-centre Phase III Trial of TPF Plus Concomitant Treatment With Cisplatin and Radiotherapy Versus Concomitant Cetuximab and Radiotherapy in Locally Advanced, Unresectable Head and Neck Cancer.
Open Label Randomized, Multi-centre Phase III Trial of TPF Plus Concomitant Treatment With Cisplatin and Radiotherapy Versus Concomitant Cetuximab and Radiotherapy in Locally Advanced, Unresectable Head and Neck Cancer.
Enrollment Status: Completed
Publish Date: May 24, 2019
Intervention Type: Other
Study Phase: Phase 3
A Phase II Trial With Radiotherapy Plus Cetuximab to Evaluate Specific Survival Free of Laryngectomy in Patients With Resectable and Locally Advanced Larynx Cancer, After Treatment With TPF
A Phase II Trial With Radiotherapy Plus Cetuximab to Evaluate Specific Survival Free of Laryngectomy in Patients With Resectable and Locally Advanced Larynx Cancer, After Treatment With TPF
Enrollment Status: Completed
Publish Date: April 11, 2019
Intervention Type: Drug, Procedure
Study Phase: Phase 2
View 1 Less Clinical Trial

23 Total Publications

Cardiac magnetic resonance to detect different patterns of myocardial injury in patients receiving immune checkpoint inhibitors.
Cardiac magnetic resonance to detect different patterns of myocardial injury in patients receiving immune checkpoint inhibitors.
Journal: Revista espanola de cardiologia (English ed.)
Published: July 06, 2021

Frequently Asked Questions about Juan J. Cruz

Is Juan J. Cruz a top-rated expert for Febrile Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Juan J. Cruz is classified as an Experienced expert for Febrile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Juan J. Cruz participate in research or clinical trials?

Yes. Juan J. Cruz has published 23 articles and abstracts on conditions like Febrile Neutropenia. You can view a list of Juan J. Cruz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cruz's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile